Identification of MEK162 as a Radiosensitizer for the Treatment of Glioblastoma

Ravi S. Narayan, Ana Gasol, Paul L. G. Slangen, Fleur M. G. Cornelissen, Tonny Lagerweij, Hou Y. Y. E. Veldman, Rogier Dik, Jaap van den Berg, Ben J. Slotman, Tom Wurdinger, Daphne A. Haas-Kogan, Lukas J. A. Stalpers, Brigitta G. Baumert, Bart A. Westerman, Jan Theys, Peter Sminia*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Web of Science)
Original languageEnglish
Pages (from-to)347-354
Number of pages8
JournalMolecular Cancer Therapeutics
Volume17
Issue number2
DOIs
Publication statusPublished - 1 Feb 2018

Keywords

  • ADJUVANT TEMOZOLOMIDE
  • MICHAELIS-MENTEN
  • KINETIC SYSTEMS
  • CELL-SURVIVAL
  • OPEN-LABEL
  • CANCER
  • INHIBITORS
  • RADIATION
  • RADIOTHERAPY
  • EGFR

Cite this